These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12587970)

  • 1. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.
    Chrystyn H
    Respir Med; 2003 Feb; 97(2):181-7. PubMed ID: 12587970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaching correct use of inhaled medications.
    Rokosky JM
    Home Healthc Nurse; 2005 Dec; 23(12):766-74; quiz 775-6. PubMed ID: 16331059
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaler and spacer use in obstructive airway diseases.
    Jones MD; Yeager H
    Am Fam Physician; 1990 Oct; 42(4):1007-13. PubMed ID: 2220509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do all dry powder inhalers show the same pharmaceutical performance?
    Taylor A; Gustafsson P
    Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endobronchial bronchodilators].
    Yernault JC
    Rev Med Brux; 1994; 15(4):277, 280-1. PubMed ID: 7939004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Easyhaler--ideal dry powder inhaler].
    Andrzej E; Małgorzata BE
    Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
    Tarsin W; Assi KH; Chrystyn H
    J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General factors influencing drug delivery to the lung.
    Ganderton D
    Respir Med; 1997 Nov; 91 Suppl A():13-6. PubMed ID: 9474361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study.
    Verver S; Poelman M; Bögels A; Chisholm SL; Dekker FW
    Fam Pract; 1996 Feb; 13(1):35-40. PubMed ID: 8671102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD].
    Sliwiński P; Chazan R; Dąbrowiecki P; Jahnz-Różyk K; Mróz R; Pirożyński M
    Pneumonol Alergol Pol; 2014; 82(3):300-10. PubMed ID: 24793155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Acoustic-Based Method to Detect and Quantify the Effect of Exhalation into a Dry Powder Inhaler.
    Holmes MS; Seheult JN; O'Connell P; D'Arcy S; Ehrhardt C; Healy AM; Costello RW; Reilly RB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):247-53. PubMed ID: 25393346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which dry powder inhaler should be chosen?
    Kuziemski K
    Respiration; 2009; 78(3):356; author reply 357-8. PubMed ID: 19602872
    [No Abstract]   [Full Text] [Related]  

  • 20. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma.
    Bisgaard H; Klug B; Sumby BS; Burnell PK
    Eur Respir J; 1998 May; 11(5):1111-5. PubMed ID: 9648964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.